Tuberculosis burden in Ethiopia from 1990 to 2016: evidence from the Global Burden of Diseases 2016 Study by Deribew, Amare et al.
              
              Tuberculosis Burden…                                                                                     Amare D. et al.                      
 
 




Tuberculosis Burden in Ethiopia from 1990 to 2016: Evidence from 
the Global Burden of Diseases 2016 Study 
 
Amare Deribew1,2*, Kebede Deribe3,4, Tariku Dejene5, Gizachew Assefa 
Tessema6,7,Yohannes Adama Melaku8,9, Yihune Lakew10, Azmeraw 
T.Amare11,12, Tolessa Bekele13, Semaw F. Abera8,14,15 ,  Muluken Dessalegn16, 
Andargachew Kumsa17, Yibeltal Assefa18, Hmwe Kyu19,  Scott D Glenn19 , 






Citation: Amare Deribew, Kebede Deribe, Tariku Dejene, Gizachew 
Assefa Tessema,Yohannes Adama Melaku, Yihune Lakew, Azmeraw 
T.Amare, Tolessa Bekele, Semaw F. Abera,  Muluken Dessalegn, 
Andargachew Kumsa, Yibeltal Assefa, Tuberculosis Burden in 
Ethiopia from 1990 to 2016: Evidence from the Global Burden of 
Diseases 2016 Study. Ethiop J Health Sci.2017;28(4): 
447.doi:http://dx.doi.org/10.4314/ ejhs.v27i5.2  
Received: March 7, 2018 
Accepted: April 20, 2018 
Published: September 1, 2018  
Copyright: © 2018 Amare Deribew, et al. This is an open access 
article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author and source 
are credited. 
Funding: Nil 
Competing Interests: The authors declare that this manuscript was 
approved by all authors in its form and that no competing interest 
exists. 
Affiliation and Correspondence: 
1St. Paul Millennium Medical College, Addis Ababa, 
Ethiopia 
2Nutrition International, Ethiopia 
3Wellcome Trust Brighton & Sussex Centre for Global 
Health 4Research, Brighton & Sussex Medical School, 
Falmer, Brighton, UK  
4School of Medicine, Addis Ababa University 
5Center for Population Studies, Addis Ababa University, 
Addis Ababa, Ethiopia 
6School of Public Health, University of Adelaide, Adelaide, 
Australia 
7Department of Reproductive Health, Institute of Public 
Health, University of Gondar, Gondar, Ethiopia 
8School of Public Health, Mekelle University, Mekelle, 
Ethiopia 
9School of Medicine, University of Adelaide, Adelaide, 
Australia 
10Ethiopian Public Health Association, Addis Ababa, 
Ethiopia 
11College of Medicine and Health Sciences, Bahir Dar 
University, Bahir Dar, Ethiopia 
12Department of Epidemiology, University of Groningen, 
Groningen, the Netherlands 
13Department of Public Health, College of Medicine and 
Health Sciences, Madda Walabu University, Ethiopia 
14Kilte Awlaelo-Health and Demographic Surveillance Site, 
Tigray, Ethiopia 
15Institute of Biological Chemistry and Nutrition, Hohenheim 
University, Stuttgart, Germany 16AMREF Health Africa, 
Addis Ababa, Ethiopia 
17Federal Ministry of Health, Addis Ababa, Ethiopia 
18University of Queensland, School of Public Health, 
Australia  
19Institute of Health Metrics and Evaluation, University of 
Washington 
20World Health Organization, Uganda 
            *Email: amare.deribew@gmail.com 
 
ABSTRACT   
 
BACKGROUND: The burden of Tuberculosis 
(TB) has not been comprehensively evaluated 
over the last 25 years in Ethiopia. In this study, 
we used the 2016 Global Burden of Diseases, 
Injuries and Risk Factors (GBD) data to analyze 
the incidence, prevalence and mortality rates of 
tuberculosis (TB) in Ethiopia over the last 26 
years. 
METHODS: The GBD 2016 is a mathematical 
modeling using different data source for 
Ethiopia such as verbal autopsy (VA), prevalence 
surveys and annual case notifications. Age and 
sex specific causes of death for TB were 
estimated using the Cause of Death Ensemble 
Modeling (CODEm). We used the available data 
such as annual notifications and prevalence 
surveys as an input to estimate incidence and 
prevalence rates respectively using DisMod-MR 
2.1, a Bayesian meta-regression tool. 
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RESULTS: In 2016, we estimated 219,186 
(95%UI: 182,977-265,292) new, 151,602 (95% 
UI: 126,054-180,976) prevalent TB cases and 
48,910(95% UI: 40,310-58,195) TB deaths. The 
age-standardized TB incidence rate decreased 
from 201.6/100,000 to 88.5/100,000 (with a total 
decline of 56%) between 1990 to 2016. Similarly, 
the age-standardized TB mortality rate declined 
from 393.8/100,000 to 100/100,000 between 1990 
and 2016(with a total decline of 75%).  
CONCLUSIONS: Ethiopia has achieved the 50% 
reduction of most of the Millennium 
Development Goals (MDGs) targets related to 
TB. However, the decline of TB incidence and 
prevalence rates has been comparatively slow. 
The country should strengthen the TB case 
detection and treatment programs at community 
level to achieve its targets during the Sustainable 
Development Program (SDGs)-era.   




The United Nations General Assembly endorsed 
the historical resolution of the Millennium 
Development Goals (MDG) in 2000. The 
Tuberculosis (TB) specific target of the MDG was 
to halt and began to reverse the incidence of TB 
by 2015(1,2). Despite remarkable progress during 
the MDG era globally, TB ranks to be the top 
killer infectious diseases worldwide. In 2016, 
there were 6.3 million new TB cases and 1.3 
million TB deaths (3). 
In Ethiopia, TB is still a major public health 
problem (1-3). The country is still among the 22 
high TB burden countries with high number of 
missed and infectious TB cases in the community 
(1-3). The prevalence and incidence of TB in 
Ethiopia in 2014 were 211 and 214 per 100,000 
populations respectively (4).  Increasing the trends 
of multidrug resistance TB (2% among new cases 
in 2006 vs. 4.5% among new cases in 2016) is a 
serious public health challenge for the country 
(4,5). TB is among the top ten causes of admission 
and deaths in adults in Ethiopia (6). In line with 
the Sustainable Development Goals (SDGs), 
Ethiopia recently launched a five years’ ambitious 
Health Sector Transformation Plan (HSTP) to 
address major diseases of public health importance 
including TB (6). Information revolution is one of 
the core agenda items of the HSTP to inform 
decision makers for timely action.  However, 
Ethiopia still does not have a strong health 
management information system to capture the 
burden of TB and track the progresses of TB 
interventions. Because of weak health information 
system and very few national surveys, the burden 
of TB was not comprehensively assessed in 
Ethiopia over the last 3 decades. In the last few 
years, there were few TB studies with limited 
geographic areas (5) that may not provide national 
representative information.   In this article, we 
used the Global Burden of Disease Study (GBD) 
2016 data (7-11) to assess the mortality, incidence, 
prevalence and Disability-adjusted Life Years 
Lost (DALY) rates of TB over the last 26 years. 
The rationale of using the GBD data include: i) 
GBD modeling strategy provides nationally 
representative estimates which cannot be obtained 
through small scale studies or surveys; ii) GBD 
uses standard modeling approach globally and our 
finding (Ethiopian performance) can be compared 
with others who are using GBD; iii) The study 
provides evidence on the achievement of Ethiopia 
on the MDG targets and the findings will also 
serve as a baseline for future tracking of TB 
targets. The performance of Ethiopia cannot be 
measured by data from small scale surveys; iv) 
Lastly, the study also helps decision makers to 




Ethiopian population (approximately 100 million) 
is the second largest in Africa with  diverse 
population mix and unique cultural heritage (6). 
The GBD 2016 data were used to identify the 
trends in the incidence, prevalence and mortality 
rates of TB.  The GBD 2016 utilizes available 
sources of data and rigorous analysis to estimate 
trends in the burden of TB for 195 countries and 
territories. The detailed methods used to estimate 
the TB burden have been published elsewhere (11-
13), and we provided a detailed description of the 
modeling in the following section. 
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Data sources: This study used a mathematical 
modeling using the GBD data. The GBD 2016 
used a different data sources for Ethiopia 
(http://ghdx.healthdata.org/). The key sources of 
data for TB include verbal autopsy (VA) studies, 
national and subnational tuberculosis prevalence 
surveys that are published, published population-
based tuberculin surveys, case notifications and 
cohort studies reporting on the risk of developing 
active TB disease as a function of induration size.  
We excluded unpublished data and hospital 
records.  
 
Data analysis and modeling : Causes of death by 
age groups, sex and year for TB were estimated 
using the Cause of Death Ensemble modeling 
(CODEm). A detailed description of CODEm is 
reported elsewhere (14-17).  In brief, CODEm 
tests a wide range of models such as mixed effects 
linear models and spatial-temporal Gaussian 
process regression (ST-GPR) models using 
various combinations of covariates and constructs 
an ensemble model based on the performance of 
the different models (15). All models are assessed 
using out-of-sample predictive validity tests and 
an ensemble of models that perform best is 
selected. Non-fatal TB modeling prevalence and 
incidence rates of TB were estimated using a 
Bayesian Regression model using the input data 
such as prevalence surveys and case notifications 
(http://ghdx.healthdata.org/gbd-2016/data-input-
sources). The detailed methodology is described 
elsewhere (11).  First, we estimated the risk-
weighted prevalence of latent TB infection (LTBI) 
using data from population-based tuberculin 
surveys and cohort studies examining the risk of 
developing active TB as a function of induration 
size (11). Next, we divided the inputs on 
prevalence (from TB prevalence surveys), 
incidence (estimated based on a mortality-to-
incidence ratio approach) and cause specific 
mortality estimates by the risk-weighted LTBI 
prevalence to model TB among those at risk. We 
used DisMod-MR 2.1, the GBD Bayesian meta-
regression tool to generate internally consistent 
estimates of incidence, prevalence and mortality. 
We then multiplied the DisMod-MR 2.1 outputs 
by the risk-weighted prevalence of LTBI to get 
population-level estimates of incidence and 
prevalence (11). 
 
Quality assurance: VA data were corrected for 
garbage coding based on the GBD algorithm (15). 
Garbage coding is a bias due to the assignment of 
causes of death that are not underlying causes of 
death (14). We included published articles and 
surveys. Unpublished data or reports were 
excluded.   
 
Ethical approval: The study used secondary data 
from the GBD 2016 study, and permission was 
obtained from Institute of Health Metrics and 
Evaluation at Washington University in the United 
States to utilize the data. The GBD 2016 data can 





An estimated 219,186 (95%UI: 182,977-265,292) 
incident of TB cases occurred in Ethiopia in 2016. 
The age-standardised TB incidence rate decreased 
from 201.6/100,000 to 88.5/100,000 (with a total 
decline of 56%) between 1990 to 2016. Males had 
higher TB incidence rate than females during the 
last 26 years (P-value for trend<0.05). Annualized 
rate of change (ARC) for the age-standardised 
incidence rate was -3.2%. The ARC between 
males and females was not statistically significant 
(P=0.06) (Figure 1). 
In 2016, about 151,602 (95% UI: 126054-
180,976) prevalent TB cases were estimated to 
occur in Ethiopia. The annualized rate of decline 
for the age-standardised TB prevalence rate was 
nearly 3% during the last 26 years. The age 
standardized TB prevalence rate declined by 51% 
(from 139.4/100,000 to 68.2/100,000) between 
1990 to 2016 (Figure 2).   
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Figure 1:  TB incidence cases (A) and TB incidence rate (B) by sex in Ethiopia in 2016 
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Figure 2: Number of TB prevalent cases (A) and TB prevalence rate (B) between 1990 and 2016 
 
An estimated 48,910(95% UI: 40,310-58,195) TB 
deaths occurred in 2016. The age-standardised TB 
mortality rate declined from 393.8/100,000 to 
100/100,000 between 1990 and 2016 (with a total 
decline of 75%) (Table 1). TB deaths increased as 
age increased, and males had higher TB mortality 
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Table 1: Number of deaths and mortality rate of Tuberculosis in Ethiopia, between 1990 and 2016 
 
Year Number of 
deaths 
95%UI Rate/100,000 95%UI 
1990 91150 62040 107222 393.8 265.1 472.7 
1995 84245 65653 96138 311.1 240.4 359.9 
2000 74563 63272 84064 242.6 205.4 275.0 
2005 70921 62195 79623 201.2 177.4 225.6 
2010 59597 52167 69144 145.7 128.1 167.4 
2015 49875 41423 59434 105.3 89.0 124.7 
2016 48910 40310 58195 100.0 83.4 118.5 
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An estimated of 1.8 million (95%UI: 1.5 million-
2.2 million) TB related DALY were registered in 
Ethiopia in 2016. Age-standardised TB DALY 
rate declined from 11411/100,000 in 1990 to 
2771.9/100,000 in 2016 with a total reduction of 
76%. ARC for TB DALY rate was -5.4% (Table 
2).  
 
Table 2: Number of DALY and DALY rates due to Tuberculosis between 1990 and 2016 
 





1990 3573109 2454050 4191207 11411.0 7893.6 13400.5 
1995 3277927 2587075 3759007 8936.5 7040.2 10222.8 
2000 2916341 2462535 3300836 6968.6 5921.4 7842.8 
2005 2795015 2455346 3155602 5724.0 5003.2 6437.8 
2010 2296405 1982065 2646342 4095.5 3569.1 4774.8 
2015 1886205 1574282 2238669 2924.5 2429.2 3452.9 




Ethiopia has reduced the TB mortality rate by 75% 
and the TB incidence rate by more than 50% 
during 1990 and 2016. This is in line with the 
MDG targets of halving mortality rate of TB by 
2015 and efforts to reverse the incidence of these 
diseases (1,2).  
Other reports also show that Ethiopia has 
achieved most of the MDG targets related to TB 
(18-20). Assefa and colleagues reported that TB 
incidence rate and TB mortality rate e declined by 
54% and by 72% respectively during the MDG era 
(20). The World Health Organization (WHO) 
report indicates that the performance of Ethiopia 
in reducing TB mortality and incidence rates has 
been remarkable over the last decade.  Since 2010, 
Ethiopia has reduced the TB mortality rate by 
more than 6% annually and the incidence rate of 
TB by more than 4% annually (3). The WHO 
estimates of TB prevalence and incidence rates 
were higher than the GBD estimates particularly 
in the early 1990s. However, the WHO estimates 
are lower than the GBD estimates over the years 
particularly after 2010. The GBD estimation of 
prevalence was derived from local or national 
prevalence survey (10,15). However, the WHO 
estimated TB prevalence as a product of incidence 
and duration of the diseases in the absence of 
national TB prevalence survey (15,21). Estimation 
of TB incidence rate by WHO was based on case-
notification and expert judgment (21).  
There are very limited studies in Ethiopia that 
assessed the burden of TB comprehensively 
during the MDG era. A study conducted in 
Oromia region in 2016 shows that incidence and 
prevalence rates of TB were 214/100,000 and 
109/100,000 respectively (22). The prevalence of 
bacteriologically confirmed TB at the national 
level in 2011 was 277/100,000 (23).  On the other 
hand, Berhe and colleagues reported a prevalence 
rate of bacteriologically confirmed TB of 
352/100,000 in Tigray in 2012 (24). The GBD TB 
prevalence estimates are lower than the estimates 
of the aforementioned studies (12,13). On the 
other hand, our prevalence estimates are higher 
than the estimate reported by Deribew et al in 
Jimma (108/100,000) (25) and Yimer et al in 
Gondar (80/100,000) (26).   
The performance of Ethiopia in reducing the 
burden of TB and reversing these epidemics is 
remarkable particularly since 2010 (15). Several 
factors could have helped Ethiopia to achieve the 
MDG targets. First, the commitment and 
leadership of the health sector leaders in Ethiopia 
could have helped Ethiopia to achieve most of the 
MDG targets (27). Second, the Health Extension 
Programs (HEP) in Ethiopia would have created 
an opportunity to improve access to care and 
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treatment for TB suspects. Some reports show that 
the HEP has been instrumental to make health 
services accessible to the poor (19, 27-29). It also 
improves TB case detection rates at community 
level (30). Implementation of the Directly 
Observed Treatment for TB (DOTS) over the last 
two decades could have also significant impact on 
the burden of TB in Ethiopia. Third, the 
contribution of development partners to fight TB 
(PEPFAR) has been also vital in fighting TB in 
Ethiopia. The government has used flexible 
modalities of One-plan, One-budget and One-
Report concept and effectively utilized the funding 
to scale up interventions towards TB (31). Donors’ 
funding could decline during the coming years and 
Ethiopia should strengthen the low-cost and high 
impact HEP-based interventions to sustain 
progress (6,32).  
Despite a remarkable progress, Ethiopia has 
to overcome several challenges to achieve the End 
TB Targets of reducing TB mortality by 90% and 
TB incidence rate by 80% by 2030 (33). TB/HIV 
co-infection and its impact on stigma and mental 
health problems could also be a big hurdle for the 
HIV/AIDS control program (34,35). In the rural 
part of the country, stigma and prejudices are still 
widespread which needs tailored intervention (36). 
Continuous community mobilization, stigma 
reduction, and care and support services have been 
vital for increasing utilization of ART services and 
improving retention in care that helps to reduce 
early mortality due to HIV/AIDS in Ethiopia (37).  
On the other hand, very low TB case 
detection rate and presence of infectious TB cases 
at the community without treatment poses serious 
problems on the TB control program. Despite the 
implementation of the directly-observed treatment, 
short-course for TB (DOTS) since 2000(38), the  
TB case detection rate of 36%, remains very low 
in the country (39).  So, decentralization of TB 
diagnostic and treatment services down to the 
lower health facilities and involvement of health 
extension workers in TB control program to 
revitalize and improve case detection system in 
the country is acceptable (28,40). 
On the other hand, the burden of TB is highly 
variable by region and population groups, which 
requires proper planning. Some regions have 
higher TB prevalence that needs to be addressed to 
bring equity (24,41). The TB epidemic is also 
concentrated in some vulnerable populations 
particularly in prison inmates (42,43).  The 
increasing trends of multi-drug resistant TB 
(MDR-TB), which requires expensive and more 
toxic drugs, remain a serious challenge ahead in 
the coming years (44).  
This study is based on the GBD 2016 that 
uses comprehensive data sources and rigorous 
analysis. However, the study has some limitations. 
First, the use of verbal autopsy (VA) data in 
morality estimation may introduce 
misclassification bias. Use of published articles 
could introduce publication bias since unfavorable 
findings may not be published.  
In conclusion, Ethiopia has achieved most of 
the MDG targets related to TB. However, the 
decline in TB incidence and prevalence rates has 
been slow. The country thus should strengthen TB 
case detection and treatment programs at 
community level through the HEP to reduce the 
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